GeneDx has announced the launch of its genomic testing platform on Aura, Epic’s specialty diagnostics suite. Epic is one of the largest electronic health records (EHR) vendors in the United States. Together, the companies will offer advanced genetic sequencing within EHRs. GeneDx’s tests include exome sequencing (ES), whole genome sequencing (WGS), and rapid whole genome sequencing (rWGS). UNC Health will be the first health system to adopt the GeneDx offerings through Aura.
“The Epic Aura integration for genetic testing offers significant advantages for both patients and providers. It streamlines the implementation process and enhances the clarity and accessibility of results within the electronic health record. With Aura, genetic test results are seamlessly integrated with other lab results, making them more visible and easier to find, rather than being hidden or located in a separate section. The structured format of the data also opens the door to numerous research and quality improvements down the line,” said Michael Adams, MD, a physician specializing in pediatric genetics and metabolism at UNC Health.
Health systems can now access GeneDx’s genomic testing directly within their native EHR system, enabling clinicians to more accurately and efficiently diagnose genetic conditions and guide timely, targeted treatments. GeneDx on Epic Aura empowers healthcare providers to deliver faster and more accurate diagnoses, reducing the time to treatment and improving patient outcomes.
“GeneDx is committed to providing patient-centered solutions and our use of Aura simplifies the process for healthcare providers to ensure the first step to treatment, an accurate and fast genetic diagnosis, is easily accessible at a patient’s bedside and in the exam room,” said Katherine Stueland, president and CEO of GeneDx.
“There’s a reason 8 out of 10 genetics experts rely on GeneDx for exome and genome testing. We’ve empowered thousands of clinicians with genomic insights that have changed clinical care and led to better health outcomes for their patients.”
As more health systems integrate with GeneDx on Aura, the adoption of genome and exome sequencing will continue to grow, further incorporating genetic insights into routine clinical care across numerous medical specialties including pediatrics, neonatology, pediatric neurology, genetics, and more.
